Association between lorlatinib blood concentration and adverse events and clinical impact of dose modification

作者：Yukiko Shimoda Igawa, Tsutomu Yoshida, Reiko Ando Makihara, Masahiro Torasawa, Akiko Tateishi, Yūji Matsumoto, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe · 发表于：Lung Cancer · 年份：2024 · DOI：10.1016/j.lungcan.2024.107954 · 被引用次数：12 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Lymphoma Diagnosis and Treatment